blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1905440

EP1905440 - Use of a pharmaceutical composition comprising an anticholinergic for killing microorganisms and for treating respiratory tract infections [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  06.02.2009
Database last updated on 25.09.2024
Most recent event   Tooltip06.02.2009Refusal of applicationpublished on 11.03.2009  [2009/11]
Applicant(s)For all designated states
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2008/14]
Representative(s)Hammann, Heinz, et al
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2008/14]Hammann, Heinz, et al
Boehringer Ingelheim Pharma GmbH & Co. KG Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date06120196.806.09.2006
[2008/14]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP1905440
Date:02.04.2008
Language:DE
[2008/14]
Search report(s)(Supplementary) European search report - dispatched on:EP25.04.2007
ClassificationIPC:A61K31/437, A61P11/00
[2008/14]
CPC:
A61K31/437 (EP,US); A61P11/00 (EP); A61P31/04 (EP);
A61P31/10 (EP); Y02A50/30 (EP,US)
Designated contracting states(deleted) [2008/50]
Former [2008/14]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen[2008/14]
English:Use of a pharmaceutical composition comprising an anticholinergic for killing microorganisms and for treating respiratory tract infections[2008/14]
French:Utilisation d'une composition pharmaceutique comprenant un anticholinergique pour l'élimination de micro-organismes et pour le traitement d'infections du tractus respiratoire[2008/14]
Examination procedure10.09.2008Despatch of communication that the application is refused, reason: Examination on filing A.90(5) [2009/11]
20.09.2008Application refused, date of legal effect [2009/11]
Fees paidPenalty fee
Additional fee for renewal fee
30.09.200803   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2006015970  (BOEHRINGER INGELHEIM INT [DE], et al) [X] 1-4,7-11,13-15,18 * page 1 * * page 4 * * page 6, line 4 - line 5 * * page 7, line 8 - line 16 * * page 19 - page 20 * * page 25, line 16 - line 35 * * page 28, line 30 - page 30 * * claim 19 *;
 [X]US2005239778  (KONETZKI INGO [DE], et al) [X] 1-4,7,10,13-15,18 * paragraph [0153] * * paragraph [0180] - paragraph [0198] * * paragraph [0203] - paragraph [0220] * * paragraph [0254] * * paragraph [0433] * * paragraph [0436] * * paragraph [0438] * * paragraph [0467] * * paragraph [0486] *;
 [X]WO02096423  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [X] 1-3,7,10,12 * page 46 - page 48 * * page 62, paragraph 227 * * page 63, paragraph 235 * * page 64, paragraph 252 * * page 66, paragraph 247 * * page 69, paragraph 259 * * page 72 - page 74 * * page 75, paragraph 286 * * claim 1 *;
 [X]WO2005044186  (GLAXO GROUP LTD [GB], et al) [X] 1-3,7,13 * page 15 * * claims 1-6,17,23,25,36,58,60 *;
 [X]US2005008578  (SCHMIDT FRIEDRICH [DE]) [X] 1-4,13 * page 1, paragraphs 2-4 * * page 3, paragraph 38 *;
 [X]WO03084519  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [X] 1-3,7,8,13,14,18,19 * page 3 - page 4 * * page 5, line 4 - line 16 *;
 [X]WO0232898  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [X] 1-6,13-17 * page 1 * * page 49 - page 50 * * page 53, line 8 - line 21 * * page 56 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.